These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17047914)

  • 21. Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes? [Letter to the Editor].
    Merchante-Alfaro AÁ; Pérez-Naranjo S; Abellán-Galiana P; Rubio-Puchol O
    Endocr J; 2016 Apr; 63(4):411-2. PubMed ID: 26961339
    [No Abstract]   [Full Text] [Related]  

  • 22. Reconsideration of severe hypoglycemic events in the treat-to-target trial.
    Dailey G; Strange P; Riddle M
    Diabetes Technol Ther; 2009 Aug; 11(8):477-9. PubMed ID: 19698059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged glucose requirements after intentional glargine and aspart overdose.
    Fromont I; Benhaim D; Ottomani A; Valéro R; Molines L; Vialettes B
    Diabetes Metab; 2007 Nov; 33(5):390-2. PubMed ID: 17644447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
    Rossetti P; Porcellati F; Bolli GB; Fanelli CG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
    [No Abstract]   [Full Text] [Related]  

  • 25. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
    Ocheltree SM; Hompesch M; Wondmagegnehu ET; Morrow L; Win K; Jacober SJ
    Eur J Endocrinol; 2010 Aug; 163(2):217-23. PubMed ID: 20508081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes].
    Mianowska B; Szadkowska A; Czerniawska E; Pietrzak I; Bodalski J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(4):189-93. PubMed ID: 18042313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of insulin glargine during pregnancy in a type 1 diabetic woman.
    Devlin JT; Hothersall L; Wilkis JL
    Diabetes Care; 2002 Jun; 25(6):1095-6. PubMed ID: 12032121
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 33. Mixing insulin lispro and ultralente insulin.
    Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
    Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.
    Walczak IM
    Diabetes Technol Ther; 2002; 4(5):744-5. PubMed ID: 12458569
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes.
    Holstein A; Plaschke A; Egberts EH
    Diabet Med; 2003 Sep; 20(9):779-80. PubMed ID: 12925063
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tramadol-induced hypoglycemia in a diabetic patient].
    Jonville-Bera A-; Marie A; Magba D; Gedon E; Autret-Leca E
    Therapie; 2010; 65(5):499-500. PubMed ID: 21416746
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing mistakes in patient administration of glargine and lispro.
    Schutta MH
    Diabetes Care; 2002 Jun; 25(6):1098-9. PubMed ID: 12032124
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the continuous glucose monitoring system in Goettingen Minipigs, with a special focus on the evaluation of insulin-dependent diabetes.
    Strauss A; Tiurbe C; Chodnevskaja I; Thiede A; Timm S; Ulrichs K; Moskalenko V
    Transplant Proc; 2008 Mar; 40(2):536-9. PubMed ID: 18374123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.
    Dolci M; Mori M; Baccetti F
    Diabetes Care; 2005 Aug; 28(8):2084-5. PubMed ID: 16043769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.